BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 20 filers reported holding BENITEC BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -64.7% | 14,831 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -51.4% | 14,831 | -0.7% | 0.00% | – |
| Q1 2022 | $35,000 | -10.3% | 14,932 | 0.0% | 0.00% | – |
| Q4 2021 | $39,000 | -26.4% | 14,932 | 0.0% | 0.00% | – |
| Q3 2021 | $53,000 | -15.9% | 14,932 | 0.0% | 0.00% | – |
| Q2 2021 | $63,000 | -30.8% | 14,932 | -15.4% | 0.00% | – |
| Q1 2021 | $91,000 | – | 17,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $1,796,000 | 0.06% |
| Atom Investors LP | 37,335 | $87,000 | 0.04% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 492,880 | $57,000 | 0.02% |
| WealthTrust Axiom LLC | 12,950 | $30,000 | 0.01% |
| UBS Group AG | 347 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 43 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,813 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 59,566 | $139,000 | 0.00% |